A novel high-throughput neutralization assay for supporting clinical evaluations of human cytomegalovirus vaccines. (Q44821407)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21888937%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

A novel high-throughput neutralization assay for supporting clinical evaluations of human cytomegalovirus vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21888937%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21888937%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Adam C Finnefrock

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21888937%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Aimin Tang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21888937%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Fengsheng Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21888937%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Daniel C Freed

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21888937%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Danilo R Casimiro

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21888937%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Tong-Ming Fu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21888937%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

English

0 references

publication date

31 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21888937%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21888937%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21888937%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

8350-8356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21888937%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21888937%20AND%20SRC:MED&resulttype=core&format=json

Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

Progress toward an elusive goal: current status of cytomegalovirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

Maternal immunity and prevention of congenital cytomegalovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

The outcome of congenital cytomegalovirus infection in relation to maternal antibody status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

Vaccine prevention of maternal cytomegalovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

Human cytomegalovirus: propagation, quantification, and storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

A rapid microneutralization assay for cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

Novel microneutralization assay for HCMV using automated data collection and analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

Development of an efficient fluorescence-based microneutralization assay using recombinant human cytomegalovirus strains expressing green fluorescent protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

A 384-well cell-based phospho-ERK assay for dopamine D2 and D3 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

Improvement of a quantitative cell tropism assay for rapid and reliable characterization of human cytomegalovirus mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.086